Company Data
NuCana plc
Ticker
NCNA
Current Price
$1.06 10.42%
Market Cap
$2.4M
Price Target
Refer to Report
Volume
69.5K
52wk Range
$0.85 - $19.41
Overview
NuCana PLC is a biopharmaceutical company focused on improving treatment outcome for cancer patients by ProTide technology. Utilising proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. Geographically operates through the region of the United States.